These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 12007923)
1. Effects of intracerebroventricular administration of the CCK(1) receptor antagonist devazepide on food intake in rats. Ebenezer IS Eur J Pharmacol; 2002 Apr; 441(1-2):79-82. PubMed ID: 12007923 [TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK. Brenner LA; Ritter RC Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920 [TBL] [Abstract][Full Text] [Related]
3. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor. Ebenezer IS; Baldwin BA Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271 [TBL] [Abstract][Full Text] [Related]
4. Elevation of feed intake in parasite-infected lambs by central administration of a cholecystokinin receptor antagonist. Dynes RA; Poppi DP; Barrell GK; Sykes AR Br J Nutr; 1998 Jan; 79(1):47-54. PubMed ID: 9505802 [TBL] [Abstract][Full Text] [Related]
5. CCK-A receptor antagonists have selective effects on nutrient-induced food intake suppression in rats. Trigazis L; Vaccarino FJ; Greenwood CE; Anderson GH Am J Physiol; 1999 Feb; 276(2):R323-30. PubMed ID: 9950908 [TBL] [Abstract][Full Text] [Related]
6. The effect of centrally administered CCK-receptor antagonists on food intake in rats. Corp ES; Curcio M; Gibbs J; Smith GP Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553 [TBL] [Abstract][Full Text] [Related]
7. Devazepide fails to reverse the inhibitory effect of interleukin-1beta on food intake in female rats. Butera PC; Briffa CF; Whitaker EE Physiol Behav; 2004 Oct; 82(5):777-83. PubMed ID: 15451641 [TBL] [Abstract][Full Text] [Related]
8. CCK is involved in both peripheral and central mechanisms controlling food intake in chickens. Rodríguez-Sinovas A; Fernández E; Manteca X; Fernández AG; Goñalons E Am J Physiol; 1997 Jan; 272(1 Pt 2):R334-40. PubMed ID: 9039026 [TBL] [Abstract][Full Text] [Related]
9. Effect of a cholecystokinin-A receptor blocker on protein-induced food intake suppression in rats. Trigazis L; Orttmann A; Anderson GH Am J Physiol; 1997 Jun; 272(6 Pt 2):R1826-33. PubMed ID: 9227596 [TBL] [Abstract][Full Text] [Related]
10. Serotonin receptor blockade increases food intake and body weight after total gastrectomy in rats. Zittel TT; Glatzle J; Weimar T; Kless S; Becker HD; Jehle EC J Surg Res; 2002 Aug; 106(2):273-81. PubMed ID: 12175978 [TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin-A receptors are involved in food intake suppression in rats after intake of all fats and carbohydrates tested. Bellissimo N; Anderson GH J Nutr; 2003 Jul; 133(7):2319-25. PubMed ID: 12840200 [TBL] [Abstract][Full Text] [Related]
12. The effects of a peripherally acting cholecystokinin1 receptor antagonist on food intake in rats: implications for the cholecystokinin-satiety hypothesis. Ebenezer IS Eur J Pharmacol; 2003 Feb; 461(2-3):113-8. PubMed ID: 12586206 [TBL] [Abstract][Full Text] [Related]
13. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate. Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559 [TBL] [Abstract][Full Text] [Related]
14. Role of cholecystokinin in the anorexia produced by duodenal delivery of peptone in rats. Woltman T; Reidelberger R Am J Physiol; 1999 Jun; 276(6):R1701-9. PubMed ID: 10362750 [TBL] [Abstract][Full Text] [Related]
15. Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in rats. Woltman T; Reidelberger R Am J Physiol; 1996 Dec; 271(6 Pt 2):R1521-8. PubMed ID: 8997348 [TBL] [Abstract][Full Text] [Related]
16. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats. Lu L; Zhang B; Liu Z; Zhang Z Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241 [TBL] [Abstract][Full Text] [Related]
17. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement. Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299 [TBL] [Abstract][Full Text] [Related]
18. Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity. Josselyn SA; Franco VP; Vaccarino FJ Psychopharmacology (Berl); 1996 Jan; 123(2):131-43. PubMed ID: 8741936 [TBL] [Abstract][Full Text] [Related]
19. Endogenous cholecystokinin's satiating action increases during estrus in female rats. Eckel LA; Geary N Peptides; 1999; 20(4):451-6. PubMed ID: 10458514 [TBL] [Abstract][Full Text] [Related]
20. Devazepide, a CCK(A) antagonist, attenuates the satiating but not the preference conditioning effects of intestinal carbohydrate infusions in rats. Pérez C; Lucas F; Sclafani A Pharmacol Biochem Behav; 1998 Feb; 59(2):451-7. PubMed ID: 9476995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]